Both in R&D — Physical & Biological Sciences
NRC Health vs Incyte Genomics
Over the past year NRC returned +79.8% and INCY returned +18.5%; their daily moves had a correlation of 0.11.
NRC +79.8% INCY +18.5%Growth of $1, one year, split-adjusted
| Metric | NRC | INCY |
|---|---|---|
| Price | $23.83 | $120.39 |
| Market cap | $505.7M | $24.54B |
| Today | +1.45% | +3.07% |
| 1 month | +11.8% | +2.8% |
| 6 months | +36.9% | +24.2% |
| Year to date | +27.0% | +21.9% |
| 1 year | +77.2% | +33.5% |
| Revenue growth (YoY) | +4.0% | +14.0% |
| Gross margin | 61.7% | 93.0% |
| Net margin | −9.3% | −50.4% |
| P/E (TTM) | 91.1× | 60.8× |
| Price / sales | 3.6× | 4.1× |
| Net cash | -$86.7M | $3.82B |
| Dividend yield | 2.69% | — |
| Volatility (60d) | 45.5% | 27.1% |
| Short % of float | 7.2% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).